These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 6274669)

  • 1. Suppressive action of cholecystokinin octapeptide on the behavioral effects of L-DOPA in the rat.
    Itoh S; Katsuura G
    Eur J Pharmacol; 1981 Nov; 75(4):313-6. PubMed ID: 6274669
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sedative action of cholecystokinin octapeptide on behavioral excitation by thyrotropin releasing hormone and methamphetamine in the rat.
    Katsuura G; Itoh S
    Jpn J Physiol; 1982; 32(1):83-91. PubMed ID: 6281507
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of cholecystokinin on thyrotropin releasing hormone (TRH)-induced serotonin potentiation in rats.
    Itoh S; Katsuura G
    Jpn J Physiol; 1982; 32(1):145-8. PubMed ID: 6281503
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of beta-endorphin, thyrotropin-releasing hormone and cholecystokinin on body shaking behavior in rats.
    Itoh S; Katsuura G
    Jpn J Physiol; 1982; 32(4):667-75. PubMed ID: 6294391
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypermotility induced by vasoactive intestinal peptide in the rat: its reciprocal action to cholecystokinin octapeptide.
    Itoh S; Katsuura G; Yoshikawa K
    Peptides; 1985; 6(1):53-7. PubMed ID: 3991364
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of cholecystokinin octapeptide sulphate ester and unsulphated cholecystokinin octapeptide on active avoidance behaviour in rats.
    Fekete M; Bokor M; Penke B; Telegdy G
    Acta Physiol Acad Sci Hung; 1982; 60(1-2):57-63. PubMed ID: 6306996
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modulation of passive avoidance behaviour of rats by intracerebroventricular administration of cholecystokinin octapeptide sulfate ester and nonsulfated cholecystokinin octapeptide.
    Kádár T; Fekete M; Telegdy G
    Acta Physiol Acad Sci Hung; 1981; 58(4):269-74. PubMed ID: 6291322
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structure-activity studies concerning effect of cholecystokinin octapeptide on passive avoidance behaviour of rats.
    Fekete M; Penke B; Telegdy G
    Acta Physiol Acad Sci Hung; 1981; 58(3):197-200. PubMed ID: 6291320
    [No Abstract]   [Full Text] [Related]  

  • 9. The effect of vagotomy on the satiety effects of neuropeptides and naloxone.
    Morley JE; Levine AS; Kneip J; Grace M
    Life Sci; 1982 May; 30(22):1943-7. PubMed ID: 6287135
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cholecystokinin-octapeptide suppresses stress-induced eating by inducing hyperglycemia.
    Levine AS; Morley JE
    Regul Pept; 1981 Nov; 2(6):353-7. PubMed ID: 6272376
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cholecystokinin-induced hypothermia in the rat.
    Katsuura G; Hirota R; Itoh S
    Experientia; 1981 Jan; 37(1):60. PubMed ID: 6258973
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of cholecystokinin on central monoaminergic pathways.
    Widerlöv E; Kalivas PW; Lewis MH; Prange AJ; Breese GR
    Regul Pept; 1983 May; 6(2):99-109. PubMed ID: 6308717
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of unilateral intracerebroventricular microinjections of cholecystokinin (CCK) on circling behavior of rats.
    Morency MA; Ross GM; Hesketh D; Mishra RK
    Peptides; 1987; 8(6):989-95. PubMed ID: 3441450
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of intraventricular administration of cholecystokinin octapeptide sulfate ester and unsulfated cholecystokinin octapeptide on active avoidance and conditioned feeding behaviour of rats.
    Fekete M; Szabó A; Balázs M; Penke B; Telegdy G
    Acta Physiol Acad Sci Hung; 1981; 58(1):39-45. PubMed ID: 6282048
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Behavioural effects of central and peripheral injection of various analogues and metabolites of thyrotropin releasing hormone (TRH).
    Heal DJ; Sabbagh A; Youdim MB; Green AR
    Neuropharmacology; 1981 Oct; 20(10):947-57. PubMed ID: 6795523
    [No Abstract]   [Full Text] [Related]  

  • 16. Effect of a cholecystokinin preparation on brain monoamines in the rat.
    Katsuura G; Hirota R; Itoh S
    Jpn J Physiol; 1980; 30(5):811-4. PubMed ID: 7463880
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of cholecystokinin octapeptide and vasoactive intestinal polypeptide on adrenocortical secretion in the rat.
    Itoh S; Hirota R; Katsuura G
    Jpn J Physiol; 1982; 32(4):553-60. PubMed ID: 6294390
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibitory effect of cholecystokinin octapeptide on vasoactive intestinal peptide-induced stimulation of adrenocortical secretion.
    Itoh S; Hirota R
    Jpn J Physiol; 1983; 33(2):301-4. PubMed ID: 6308315
    [No Abstract]   [Full Text] [Related]  

  • 19. Cholecystokinin octapeptide and gastric mechanoreceptor activity in rat brain.
    Ewart WR; Wingate DL
    Am J Physiol; 1983 Jun; 244(6):G613-7. PubMed ID: 6305211
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuropharmacological properties of V-9-M, a putative neuropeptide derived from procholecystokinin, in the rat.
    Takashima A; Itoh S
    Can J Physiol Pharmacol; 1989 Mar; 67(3):223-7. PubMed ID: 2501013
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.